1. Broad RTK-targeted therapy overcomes molecular heterogeneity-driven resistance to cetuximab via vectored immunoprophylaxis in colorectal cancer. Issue 1 (1st November 2016) Authors: Hu, Shi; Dai, Haibin; Li, Tian; Tang, Ying; Fu, Wenyan; Yuan, Qingning; Wang, Feifei; Lv, Gaojian; Lv, Yuanyuan; Fan, Xiaoyan; Zhang, Sheng; Jin, Ruobing; Shen, Yafeng; Lin, Fangxing; Ye, Xuting; Ding, Min; Yang, Yongji; Lei, Changhai Journal: Cancer letters Issue: Volume 382:Issue 1(2016) Page Start: 32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cardiac adenovirus-associated viral Presenilin 1 gene delivery protects the left ventricular function of the heart via regulating RyR2 function in post-ischaemic heart failure. (26th November 2018) Authors: Li, Tian; Shen, Yafeng; Su, Li; Fan, Xiaoyan; Lin, Fangxing; Ye, Xuting; Ding, Dianer; Tang, Ying; Yang, Yongji; Lei, Changhai; Hu, Shi Journal: Journal of drug targeting Issue: Volume 26:Number 10(2018) Page Start: 895 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Targeting RyR2 with a phosphorylation site–specific nanobody reverses dysfunction of failing cardiomyocytes in rats. Issue 6 (18th March 2019) Authors: Li, Tian; Shen, Yafeng; Lin, Fangxing; Fu, Wenyan; Liu, Shuowu; Wang, Chuqi; Liang, Jizhou; Fan, Xiaoyan; Ye, Xuting; Tang, Ying; Ding, Min; Yang, Yongji; Lei, Changhai; Hu, Shi Journal: FASEB journal Issue: Volume 33:Issue 6(2019) Page Start: 7467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗